Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease

Kidney International

Volumn 51, Issue 5, 1997, Pages 1583-1589

  Corna, D ^a   Morigi, M ^a   Facchinetti, D ^a   Bertani, T ^a   Zoja, C ^a   Remuzzi, G ^a  

^a Center for Organ Transplantation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; UREA NITROGEN BLOOD LEVEL;

EID: 0030944041     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.217     Document Type: Article

References (41)

1. J.R. Howie B.J. Helver The immunology and pathology of NZB mice Adv Immunol 9 1968 215 255
2. A.N. Theofilopoulos F.J. Dixon Etiopathogenesis of murine SLE Immunol Rev 55 1981 179 216
3. M.H. Foster B. Cizman M.P. Madaio Nephritogenic autoantibodies in systemic lupus erythematosus: Immunochemical properties, mechanisms of immune deposition, and genetic origins Lab Invest 69 1993 494 503
4. W.J.M. Tax C. Kramers Mc.J. van Bruggen J.H.M. Berden Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus Kidney Int 48 1995 666 673
5. G.J. Fournié P. Druet Towards understanding the pathogenesis of SLE Nephrol Dial Transplant 11 1996 10 23
6. R.-M. Termaat K.J.M. Assmann H.B.P.M. Dijkman F. van Gompel R.J.T. Smeenk J.H.M. Berden Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms Kidney Int 42 1992 1363 1371
7. D. Malide I. Londono P. Russo M. Bendayan Ultrastructural localization of DNA in immune deposits of human lupus nephritis Am J Pathol 143 1993 304 311
8. K. Kramers M. Hylkema R.-M. Termaat K. Brinkman R. Smeenk I. Berden Histones in lupus nephritis Exp Nephrol 1 1993 224 228
9. R.M. Termaat K. Brinkman F. van Gompel L.P. Van Den Heuvel J.H. Veerkamp R.J. Smeenk J.H. Berden Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes J Autoimmun 3 1990 531 545
10. T. Schmiedeke F. Stoeckl S. Muller Y. Sugisaki S. Batsford R. Woitas A. Vogt Glomerular immune deposits in murine lupus models may contain histones Clin Exp Immunol 90 1992 453 458
11. A.D. Steinberg M.C. Gelfand J.A. Hardin D.T. Lowenthal Therapeutic studies in NZB/W mice. III. Relationship between renal status and efficacy of immunosuppressive drug therapy Arthritis Rheum 18 1975 9 14
12. B.A. Kiberd I.D. Young Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide J Lab Clin Med 124 1994 496 506
13. P.J. Russell J.D. Hicks Cyclophosphamide treatment of renal disease in (NZBxNZW) F1 hybrid mice Lancet 1 1968 440 446
14. J.V. Donadio R.J. Glassock Immunosuppressive drug therapy in lupus nephritis Am J Kidney Dis 21 1993 239 250
15. A.C. Allison E.M. Eugui Mycophenolate mofetil, a rationally designed immunosuppressive drug Clin Transplant 7 1993 96 112
16. H.W. Sollinger Mycophenolate mofetil Kidney Int 48 Suppl 52 1995 S14 S17
17. E.M. Eugui A. Mirkovich A.C. Allison Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice Scand J Immunol 33 1991 175 183
18. D.O. Taylor R.D. Ensley S.L. Olsen D. Dunn D.G. Renlund Mycophenolate mofetil (RS-61443): Preclinical, clinical, and three-year experience in heart transplantation J Heart Lung Transplant 13 1994 571 582
19. J.K. Kirklin R.C. Bourge D.C. Naftel W.R. Morrow M.H. Deierhoi R.S. Kauffman C. White-Williams R.I. Nomberg W.L. Holman D.C. Smith Jr Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): Initial clinical experience J Heart Lung Transplant 13 1994 444 450
20. H.W. Sollinger M.H. Deierhoi F.O. Belzer A. Diethelm R.S. Kauffman RS-61443 — A phase I clinical trial and pilot rescue study Transplantation 53 1992 428 432
21. G.M. Danovitch Mycophenolate mofetil in renal transplantation: Results from the U.S. randomized trials Kidney Int 48 Suppl 52 1995 S93 S96
22. European Mycophenolate Mofetil Cooperative Study Group Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection Lancet 345 1995 1321 1325
23. M.H. Schiff R. Goldblum M.M.C. Rees 2-Morpholinoethyl mycophenolic acid (ME-MPA) in the treatment of refractory rheumatoid arthritis (RA) Arthritis Rheum 33 1990 s.l55
24. S.M. Read D.H. Northcote Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein Anal Biochem 116 1981 53 64
25. S. Wallenstein C.L. Zucker J.L. Fleiss Some statistical methods useful in circulation research Circ Res 47 1980 1 9
26. M. Waer B. Van Damme P. Leenaerts L. Roels E. Van Den Schueren M. Vandeputte P. Michielsen Treatment of murine lupus nephritis with cyclophosphamide or total lymphoid irradiation Kidney Int 34 1988 678 682
27. L.A. Rubin M.B. Urowitz D.D. Gladman Mortality in systemic lupus erythematosus: The bimodal pattern revisited Q J Med 216 1985 87 98
28. R.P. Kimberly Pulse methylprednisolone in SLE Clin Rheum Dis 8 1982 261 278
29. H.A. Austin III J.H. Klippel J.E. Balow N.G. le-Riche A.D. Steinberg P.H. Plotz J.L. Decker Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 1986 614 619
30. M. Blank M. Ben-Bassat Y. Shoenfeld The effect of cyclosporin A on early and late stages of experimental lupus Arthritis Rheum 35 1992 1350 1355
31. C. Entani K. Izumino H. Iida M. Fujita M. Asaka M. Takata S. Sasayama Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice Nephron 64 1993 471 475
32. L. Ozmen D. Roman M. Fountoulakis G. Schmid B. Ryffel G. Garotta Experimental therapy of systemic lupus erythematosus: The treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis Eur J Immunol 25 1995 6 12
33. 1mice J Exp Med 179 1994 305 310
34. N.L. Carteron D. Wofsy C. Schimenti T.H. Ermak F(ab′)2 anti-CD4 and intact anti-CD4 monoclonal antibodies inhibit the accumulation of CD4+ T cells, CD8+ T cells, and B cells in the kidneys of lupus-prone NZB/NZW mice Clin Immunol Immunopathol 56 1990 373 383
35. G. Remuzzi C. Zoja T. Bertani Glomerulonephritis Curr Opin Nephrol Hypertens 2 1993 465 474
36. S.R. Holdsworth T.J. Neall C.B. Wilson Abrogation of macrophage dependent injury in experimental glomerular nephritis in the rabbit. Use of an anti-macrophage serum J Clin Invest 68 1981 686 698
37. P.J. Russell J.D. Hicks F.M. Burnet Cyclophosphamide treatment of kidney disease in (NZBxNZW) F1 mice Lancet 1 1966 1279 1284
38. M.C. Gelfand A.D. Steinberg R. Nagle J.H. Knepshield Therapeu-tic studies in NZB/W mice. 1. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination Arthritis Rheum 15 1972 239 246
39. B.H. Hahn M.K. Bagby T.R. Hamilton C.K. Osterland Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in NZB/NZW mice Arthritis Rheum 16 1973 163 170
40. M.G. Jones G. Harris Prolongation of life in female NZB/NZW (F1) hybrid mice by cyclosporin A Clin Exp Immunol 59 1985 1 9
41. K. Takabayashi T. Koike K. Kurasawa Matsumura Ryutaro S. Toshiko T. Hisao I. Isao Y. Takashi Y. Sho Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus Clin Immunol Immunopathol 51 1989 110 117